Over $4.7 Million Raised at Gala for Diabetes Research Support
Fundraising Success at Connect+Cure Gala
More than 800 attendees participated in an impressive fundraising event, the Connect+Cure Gala, which successfully raised $4.7 million to enhance research and various programs at the University of Oklahoma Health Harold Hamm Diabetes Center. This event showcased a tremendous commitment from the community to support diabetes research and the organization’s initiatives.
Investment in Diabetes Research and Support
The funds raised during this gala will primarily be directed towards critical research efforts, alongside initiatives aimed at diabetes outreach and prevention. An important part of this financial support also goes to sponsor children for Camp Blue Hawk, an esteemed residential summer camp designed specifically for youth aged 9 to 17 living with Type 1 diabetes. Such efforts not only provide recreational opportunities for children but also enhance their understanding and management of diabetes.
Celebrating Contributions of Distinguished Guests
Emceeing the event was Robin Marsh, a renowned Emmy Award-winning journalist associated with KWTV News 9 in Oklahoma City. The evening was further enriched by a captivating performance from eight-time Grammy Award winner Carrie Underwood, showcasing the blend of celebration and philanthropy throughout the night.
Recognition of Exceptional Research
A highlight of the evening was the awarding of the prestigious Harold Hamm International Prize for Biomedical Research in Diabetes to Professor Dr. Anette-Gabriele Ziegler, an esteemed director at the Institute of Diabetes Research. This prize is granted to distinguish significant contributions in diabetes research aimed at creating advances for Type 1 or Type 2 diabetes patients.
A Legacy of Impact and Philanthropy
Dr. Ziegler's impactful research aims to provide hope through her groundbreaking projects, including numerous long-term studies and clinical trials that contribute significantly to public health advancements. Her work has played a pivotal role in the approval of teplizumab, the first drug capable of delaying the onset of Type 1 diabetes in individuals at risk. This accomplishment emphasizes the importance of ongoing research and discovery in the pursuit of better health solutions.
Community Recognition and Award
Honoring Harold Hamm's extraordinary contributions, the University of Oklahoma also presented him with the inaugural Crystal Seed Sower Award. This award recognizes substantial philanthropic support that influences and shapes institutions positively. Thanks to Hamm's generosity, the OU Health Harold Hamm Diabetes Center has evolved into a beacon of excellence in diabetes research.
Future Outlook for Diabetes Research
The continuous growth of funding from the National Institutes of Health illustrates the center's enhanced research capacity. Under Hamm's guidance, the center’s research funding surged impressively from $5 million to $33 million, enabling more extensive and innovative research studies.
Commitment to Community Health
OU President Joseph Harroz Jr. acknowledged the tremendous contributions looking forward to address the ongoing diabetes crisis, emphasizing Hamm's enduring impact on the health and well-being of the community. His philanthropy not only reflects compassion but underscores a profound belief in the transformative power of scientific research.
About the University of Oklahoma
Established in 1890, the University of Oklahoma stands as a public research university with extensive campuses dedicated to serving the educational, cultural, and health care needs of students and the broader community. The OU Health Campus, one of the leading academic health centers in the nation, comprises several health profession colleges and caters to a diverse population, preparing the next generation of health professionals.
Frequently Asked Questions
What was the purpose of the Connect+Cure Gala?
The Connect+Cure Gala aimed to raise funds to support diabetes research and outreach programs at the University of Oklahoma Health Harold Hamm Diabetes Center.
Who was awarded the Harold Hamm International Prize?
Professor Dr. Anette-Gabriele Ziegler received the Harold Hamm International Prize for Biomedical Research in Diabetes for her remarkable contributions to the field.
What types of programs will benefit from the raised funds?
The majority of the funds will support diabetes research and outreach programs, including sponsoring participants for Camp Blue Hawk.
How much funding was raised at the gala?
More than $4.7 million was raised during the Connect+Cure Gala to enhance diabetes research and prevention initiatives.
Why is Harold Hamm significant to the diabetes community?
Harold Hamm's philanthropic efforts have significantly advanced diabetes research, making the OU Health Harold Hamm Diabetes Center a national leader in the field.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.